LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
Clinical trial NCT02888236 · COMPLETED
Trial details
- NCT number
- NCT02888236
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-06-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.